key: cord-0844099-caey9f49
authors: Rajae, Ben CHAIB.; Mohammed, A.A.B.D.I.; Douaa, J.A.K.H.J.O.U.K.H.; Manal, M.E.R.B.O.U.H.; Ikram, M.E.K.K.A.O.U.I.; Samia, B.E.R.R.I.C.H.I.; Ghizlane, E.L.A.I.D.O.U.N.I.; H.bkiyar; B.Housni
title: Spontaneous gas effusions: A rare complication of covid 19
date: 2021-06-21
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2021.102508
sha: a4a30a66b249c0187fb490e4fa592795b4895c52
doc_id: 844099
cord_uid: caey9f49

Spontaneous gas effusion unrelated to assisted ventilation is a newly recognized complication of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The objective of the present study was to examine the incidence, risk factors and the outcomes of Spontaneous gas effusions. 610 cases were analyzable, with 3 patients developing spontaneous gas effusion. This latter was associated with increased intubation and a trend towards death in one case. Drainage was required in two cases. In conclusion, spontaneous gas effusions appeared to be a rare complication of severe acute respiratory syndrome. Further research is needed to investigate its pathogenesis.

Spontaneous gas effusion unrelated to assisted ventilation is a newly recognized complication of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The objective of the present study was to examine the incidence, risk factors and the outcomes of Spontaneous gas effusions. 610 cases were analyzable, with 3 patients developing spontaneous gas effusion. This latter was associated with increased intubation and a trend towards death in one case. Drainage was required in two cases. In conclusion, spontaneous gas effusions appeared to be a rare complication of severe acute respiratory syndrome. Further research is needed to investigate its pathogenesis Introduction:

COVID-19 a new pandemic has become worldwide and manifests mainly by respiratory symptoms. Gas effusions may be spontaneous or secondary (traumatic or iatrogenic) [1] . Iatrogenic pneumothorax may occur during mechanical ventilation (invasive or non-invasive) or during intubation. During the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic spontaneous gas effusions were a rare complication.

In this paper,we will describe3 cases of spontaneous gas effusions (two pneumothoraxes and one pneumoediastinum)with SARS COV 2 pneumopathy confirmed by polymerase chain reaction (PCR) and chest scan Case Report:

We report the case of a 38-year-old patient with no medical history who was admitted to the intensive care unit for the management of respiratory distress His history reveals an influenza-like syndrome dating back to 08 days, a fever of 39.2°C, arthralgia, myalgia associated with a dry cough, and anosmia with the notion of contact with a COVID-19 positive patient.

On his admission, clinical examination revealed a conscious patient, tachypneic at 24 cycles/min with pulse oxymetry at 74% on room air and 89% under 15 L / min of oxygen under high concentration mask, a heart rate of 82 beats per minute, and blood pressure at 122/65 mm Hg, with no evidence of right or left heart failure. Pulmonary auscultation found basithoracic crackles bilaterally. Blood gas analysis revealed a pH7.3 of, a PaO 2 56 of mmHg, a PaCO 2 32 of mmHg Biological evaluation revealed an inflammatory syndrome, with hyperleukocytosis at18730 lymphopenia at 460 cells / μ L, C-reactive protein at 116 mg / L procalcitonin at 0.17 ng / ml,and ferritin at1502 ,fibrinogen level 7. 9 g/lthe rest was normal. The chest scan was showed bilateral, peripheral, and subpleural ground-glass opacities classified CORADS 5 with lung damage superior to 75% involvement associated with a pneumomediastinum and subcutaneous emphysema of the axillary, cervical, and anterior thoracic soft parts. (Figure 1 ), polymerase chain reaction (PCR) for covid 19 infection was positive Therapeutic protocol associating azithromycin, dexamethasone 6mg/d kardegic 160 mg/d Vit C, Zinc and a curative anticoagulation Enoxaparin 100Ui /kg*2/d.a Bi-anti biotherapy based on triaxon 2g/d and ciprofloxacin 200 mg/12h was initiated The patient received a dose of tocilizumab 400 mg after 48 hours. The evolution was favorable with the improvement of respiratory symptoms, and our patient was declared cured after 31 days and 2 negative PCRs on nasopharyngeal swabs at 24 hours intervals. Case2 :

A 47-year-old patient with a pathological history of high blood pressure, diabetes, chronic renal failure with preserved diuresis, and a baseline creatinine of 25 mg/l, admitted to the intensive care unit for acute respiratory failure due to pneumonia caused by SARS CoV 2, evolving for 08 days. The clinical examination on admission showed a conscious patient, hemodynamically stable with a blood pressure of 135/75 mmHg, a heart rate of 75 beats per minute, and pulse oxymetry of 70% on room air and 93% on 3L/min of oxygen. The transthoracic echocardiography showed a left ventricle with preserved global systolic function with EF at 60%, normal filling pressures, absence of valvulopathies, with a non-dilated right ventricle of normal function, dry pericardium Blood gas analysis revealed a pH7.36 of, a PaO 2 50 of mmHg, a PaCO 2 32 of mmHg The biological evaluation revealed an inflammatory syndrome, with hyperleukocytosis to12080 lymphopenia to 300 cells / μ L, C-reactive protein to 189 mg / L and procalcitonin to 2.21 ng/ml, ferritin to1387, fibrinogen level 6.2g/l hemoglobin level to 6 g / dL, renal failure with urea to 1.59 mmol / L and creatinine to 87.39 μ mol / L. The chest scan was performed showed bilateral, peripheral, and subpleural opacities in ground glass classified CORADS 5 with 75% of lung damage and basal condensations. A 66-year-old male, with a history of diabetes, was admitted to the intensive care unit for management of acute respiratory failure with chest pain on the right side of the chest that appeared suddenly 3 days earlier with dry cough. The patient had no history of chest trauma and no fever or other systemic symptoms. On examination of his vital signs, the temperature was 37 ° and blood pressure (135/75 mm Hg), and a heart rate of 77 beats per minute. He had a respiratory rate of 18 cycles per minute, oxygen saturation of 66% on room air, and 84% on 15. His body mass index was 22 kg/m2. Blood test results showed lymphopenia at 300/μ L, white blood cells at 11610, CRP 0.48mg/L .ferritin level at2797, fibrinogen at 8.1 g/l.normal hemoglobin level at 13g/dl A thoracic chest scan revealed bilateral ground-glass opacities with 80% severe parenchymal damage. The evolution was marked 07 days later by the aggravation of respiratory signs requiring oxygen therapy by a high flow nasal probe (optiflow) with a flow rate of 40/min inspired oxygen fraction 90% temperature 34 .

Thoracic radiography was carried out on the 8th day of hospitalization and showed a right pneumothorax which required thoracic drainage.

J o u r n a l P r e -p r o o f ( Figure 6 ): chest -X-Ray showed a right pneumothorax Due to the severe hypoxemia, the patient was intubated after 10 days of hospitalization with a bad evolution and death. Our research found several cases of spontaneous pneumothorax, the majority of patients were men without a history of respiratory pathology, and the usual risk factors of COVID-19 (age > 60 years, diabetes, hypertension cardiovascular diseases, etc.) were reported in some patients. This rare complication can also be observed in women, as in the study by L. Gorospe and al [4] (2 women and 2 men). And it can affect even young people with no previous history as is the case in a case report from Turkey [5] where a 24-year-old non-smoking male presented with COVID-19 pneumonia and a large left pneumothorax.

In our study spontaneous pneumothorax appeared secondarily on CT scan in two patients (d10-j13) after the onset of clinical symptoms of COVID-19) with early-onset on chest CT scan at d8 of pneumomediastinum symptomatology in one patient; all patients had initial CT scan on admission. All three patients had extensive bilateral severe pneumonia, according. and all 3 patients had repetitive intense episodes of dry cough, these latter are known to produce a sudden increase in distal airway pressure, causing an alveolar rupture and secondary gas leakage to the peribronchovascular pulmonary interstitium, from which air can dissect proximally, eventually reaching the mediastinum. This phenomenon, called the "Macklin effect", has been implicated as the cause of pneumomediastinum that occurs in certain closed-chest lesions, asthma attacks and Valsalva maneuvers [6] . Diagnosis is based on chest X-ray and/or especially chest CT scan. The frontal chest X-ray is normal in 50% of cases. It may show an areal border along the left edge of the cardiac silhouette, subcutaneous emphysema (subcutaneous hyperclarity of the cervical region), and Minnigerode's sign (presence of air in the paraesophageal region of the neck), which is an early sign of pneumomediastinum. If the front view is normal, the profile view looks for retrosternal clarity and clear lines bordering the aortic arch and left pulmonary artery. The thoracic CT scan shows air dissection of all the anatomical structures of the mediastinum and neck, may show an associated pneumo-pericardium, and allows differentiating pneumomediastinum from anterior pneumothorax. During spontaneous pneumothorax, the CT scan shows the integrity of the tracheobronchial tree and the digestive structures. The natural evolution of spontaneous pneumothorax is towards recovery, but in some cases, the pneumothorax can be associated with a tendency towards intubation and mortality especially in severe pneumonia (our 3rd case). No specific therapy seems to have proven its effectiveness. Treatment is symptomatic (bed rest, analgesics and possibly nasal oxygen therapy). Recurrences appear to be rare. Complications are exceptional. [7] Conclusion: Spontaneous gas effusions revealing SARS-CoV-2 pulmonary infection is a rare entity. It is probably secondary to a diffuse alveolar lesion causing an alveolar rupture and an air leak. The treatment in most cases is conservative but sometimes it can be associated with a tendency towards intubation and increased mortality.

The work has been reported in line with the CARE 2018 criteria [8] .

J o u r n a l P r e -p r o o f

A pneumonia outbreak asso-ciated with a new coronavirus of probable bat origin

Épidémiologie du pneumothorax en Angleterre

Pneumothorax spontané

Gorospe et all Pneumomédiastin spontané chez les patients atteints de COVID-19: une série de cas de quatre patients DOI: 10.1016 / j

Un cas de pneumothorax spontané dans la pneumonie Covid-19

Pneumomédiastin spontané et effet Macklin: aperçu et aspect en tomodensitométrie

Highlights  Several studies have demonstrated that Spontaneous gas effusion unrelated to assisted ventilation is a newly recognized complication of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  The objective of the present study was to examine the incidence, risk factors and the outcomes of Spontaneous gas effusions.  Spontaneous gas effusions during COVID-19 should not be neglected as it is associated with severe outcomes.J o u r n a l P r e -p r o o f

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement.The ethical committee approval was not required give the article type ( case report ) .However , the written consent to publish the clinical data of the patients was given and is available to check by the handling editor if needed .J o u r n a l P r e -p r o o f Consent Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions.Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Please specify the contribution of each author to the paper, e.g. study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in other ways should be listed as contributors. This is not an original research project involving human participants in an interventional or an observational study but a case report . This registration is was not required .

The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish DR BEN CHAIB Rajae DR AABDI Mohammed